Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Taisho, Yamanouchi Tie Up in Drug Discovery
August 20, 2001
- REGULATORY NEWS IN BRIEF -1-
August 20, 2001
- Labeling Requirements Outlined for Nutrient Functional Food
August 20, 2001
- Santen's Levofloxacin Eye Drop Approved in UK
August 20, 2001
- REGULATORY NEWS IN BRIEF -2-
August 20, 2001
- 40% of Consumers Use Health Food, 60% Purchase at Pharmacies/Drugstores: Survey
August 20, 2001
- Nichiiko Expects Strong Growth Based on "Branded Generics"
August 20, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
August 20, 2001
- OTC NEWS IN BRIEF
August 20, 2001
- We Don't Want Reform That Profits Only Generic Makers: EMA President
August 20, 2001
- Sankyo, UAB Discover New Antibody with Tumoricidal Activity
August 20, 2001
- Reimbursement Prices to Be Set for 142 Medical Material Categories
August 20, 2001
- ACCJ White Paper Calls For Deregulations in Healthcare Services
August 20, 2001
- Bronchodilators Recommended for COPD: NBI Seminar
August 20, 2001
- Subcommittee Discusses Prices of Medical Materials
August 20, 2001
- Novo Nordisk: InnoLet, New Insulin Kit Targeted at the Elderly
August 20, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 20, 2001
- Fresenius to Supply Artificial Kidneys to Teijin
August 20, 2001
- Compounds under R&D by Japanese Makers in US Show Rapid Increases: JETRO Survey
August 20, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 20, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…